Jason Sicklick, MD
Surgical Oncology · la Jolla, CANPI 1487700779
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Deciphera Pharmaceuticals Inc. at 37.5% of the total. Reporting peaked in 2019 at $18,864 and has fallen 55.8% since, to $8,331 in 2025. Among surgical oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $1028.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Deciphera Pharmaceuticals Inc.$26K
- F. Hoffmann-la Roche AG$24K
- Springworks Therapeutics, Inc.$6K
- Roche Molecular Systems, Inc.$4K
- Merck$4K
- GSK$2K
- plus $5K from 9 others
Across 1 payment — averaging $9576.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$10K
What the payments were for
- Consulting fees$23,73134%
- Speaking & faculty fees$22,98833%
- Travel & lodging$19,18128%
- Food & beverage$2,1503%
- Education$8501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 30 | $25,813 |
| F. Hoffmann-la Roche AG | 5 | $23,575 |
| Springworks Therapeutics, Inc. | 6 | $5,860 |
| Roche Molecular Systems, Inc. | 10 | $3,515 |
| Merck | 1 | $3,500 |
| GSK | 1 | $1,900 |
| Aadi Bioscience, Inc. | 2 | $1,550 |
| Bayer | 1 | $1,252 |
| Medtronic | 1 | $750 |
| Intera Oncology, Inc | 1 | $345 |
| Daiichi Sankyo Inc. | 1 | $263 |
| Ventana Medical Systems, Inc. | 1 | $219 |
| Johnson & Johnson | 5 | $157 |
| Foundation Medicine, Inc. | 1 | $102 |
| W. L. Gore & Associates, Inc. | 1 | $98 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered Product$23,575
- QINLOCK$21,411
- OGSIVEO$5,584
- FYARRO$1,500
- Vitrakvi$1,252
- Intera 3000 Implantable Pump$345
- FOUNDATIONONE$102
- FOUNDATIONONE HEME$102
- FOUNDATIONONE CDX$102
- FOUNDATIONFOCUS$102
- FOUNDATIONONE LIQUID$102
How this compares
$68,899 in reported general payments places this provider in the 95th percentile of 209 surgical oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in la Jolla
- Afshin BahadorSan Diego$701K
- Amir FathiFresno$255K
- Alexander ChristSanta Monica$239K
- Yanghee WooDuarte$131K
- Michael BouvetSan Diego$118K
- Yuman FongDuarte$87K
- Ronald HurstLos Angeles$76K
- Mohammed Al-TemimiSan Jose$39K
- Gagandeep SinghDuarte$38K
- Geoffrey KrampitzBurlingame$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.